Dr. Michael E. Tavernaris, MD

Dr. Tavernaris practices at Coastline Medical Services in Mary Esther, Florida.

Dr. Tavernaris' NPI, 1386888626, was assigned on April 30, 2009. Dr. Tavernaris graduated from St. George's University School of Medicine in 2008. Dr. Tavernaris holds Florida license ME116308.

Dr. Tavernaris' primary practice is Coastline Medical Services, at 208 Mary Esther Blvd, Mary Esther, FL 32569 in Okaloosa County. The practice phone is (850) 396-1110.

Dr. Tavernaris' primary practice is Coastline Medical Services in Mary Esther, Florida. Dr. Tavernaris is also affiliated with HCA Florida Fort Walton-Destin Hospital. Dmand AI also links Dr. Tavernaris to 1 more physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tavernaris practices, 2 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Tavernaris' primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Tavernaris is board certified in family medicine by the American Board of Family Medicine. Dmand AI has Dr. Tavernaris' licenses on file in 2 states: Florida and Alabama.

Dmand AI lists acid reflux, acute sinusitis, acute skin infection, aneurysm, anxiety, arthritis, bronchitis and chronic diabetes among the conditions Dr. Tavernaris treats.

CMS data shows 315 Medicare services from Dr. Tavernaris across 2 procedure codes in 2024, all of them office visits, for 65 Medicare patients. Medicare paid $27,119 for them. Every service was in an office.

CMS counts 65 Medicare patients who saw Dr. Tavernaris in 2024. The largest group is 65 to 74, with 38 patients. 74% of them have high blood pressure, and 54% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tavernaris' median patient age at 45, with 55% women.

In 2024, Dr. Tavernaris wrote 1,965 Medicare Part D claims for 100 patients. 88% of them were for generic drugs. CMS names the drug for 1,528 of them, across 56 drugs with 11 or more claims each, at $83,621 in total drug cost. In 2023, CMS named 1,158 claims across 42 drugs.

Dr. Tavernaris accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tavernaris as offering telehealth.

CMS Open Payments shows 59 general payments to Dr. Tavernaris from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. AstraZeneca Pharmaceuticals LP paid the most, $264.

Dmand AI lists 1 award for Dr. Tavernaris, most recently NCQA PCMH in 2017.

Dr. Tavernaris graduated from St. George's University School of Medicine in 2008.

Dr. Tavernaris is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.